Ivan Cheung
Corporate Officer/Principal chez EISAI CO., LTD.
Profil
Ivan Cheung is currently the Chief Executive Officer at Nextpoint Therapeutics, Inc. He is also a Director at the Pharmaceutical Research & Manufacturers of America and the Japanese Chamber of Commerce & Industry of New York, Inc. Previously, he served as the Managing Executive Officer at Eisai Co., Ltd.
Mr. Cheung's former position was Chairman & Chief Executive Officer at Eisai, Inc. Mr. Cheung received his undergraduate degree from Duke University and his MBA from Harvard Business School.
Postes actifs de Ivan Cheung
| Sociétés | Poste | Début |
|---|---|---|
| EISAI CO., LTD. | Corporate Officer/Principal | 01/07/2009 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Japanese Chamber of Commerce & Industry of New York, Inc.
 Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Director/Board Member | - |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Chief Executive Officer | 01/02/2024 |
Anciens postes connus de Ivan Cheung
| Sociétés | Poste | Fin |
|---|---|---|
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Chief Executive Officer | 31/07/2023 |
Formation de Ivan Cheung
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EISAI CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Japanese Chamber of Commerce & Industry of New York, Inc.
Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Commercial Services |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Commercial Services |
